Sanofi Pasteur Investigational Site 002 — Dallas, Texas

Sanofi Pasteur Investigational Site 002 is a clinical research site located in Dallas, Texas, United States 75234.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Sanofi Pasteur Investigational Site 002 has participated in 1 clinical trials.

Therapeutic areas: Influenza.

Sponsors: Sanofi Pasteur, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sanofi Pasteur Investigational Site 002?

Sanofi Pasteur Investigational Site 002 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sanofi Pasteur Investigational Site 002 conducted?

Sanofi Pasteur Investigational Site 002 has 1 clinical trials on record. Their work covers Influenza.

Is Sanofi Pasteur Investigational Site 002 accredited by Crixeo Health?

Sanofi Pasteur Investigational Site 002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sanofi Pasteur Investigational Site 002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.